BioCatalystWatch
BRNSWorkspace / BRNS / OverviewCompany library
BARINTHUS BIOTHERAPEUTICS PLC logo

BARINTHUS BIOTHERAPEUTICS PLC

BARINTHUS BIOTHERAPEUTICS PLC (BRNS)

Website

Price
Market cap
Next catalystExpected Q4 2026VTP-1000 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

CLY-101

Menin

Upcoming / outlook

VTP-1000

mTOR × Gluten-protein antigens

PreINDP1P2P3FilingApproved
Upcoming / outlook

CLY-101

Menin

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CLY-101

Menin

Upcoming / outlook

CLY-101

Menin

PreINDP1P2P3FilingApproved
Upcoming / outlook

VTP-1000

mTOR × Gluten-protein antigens

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

CLY-201

TYK2

PreINDP1P2P3FilingApproved
ChAdOx1 MERS

MERS-CoV antigen(s)

PreINDP1P2P3FilingApproved

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

MAGE-A3 × NY-ESO-1

PreINDP1P2P3FilingApproved

HBV surface antigens (PreS1/PreS2/S) × Modified HBV polymerase × HBV core antigen

PreINDP1P2P3FilingApproved

5T4 × PSA × PAP × STEAP

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BRNS PR & News

PR & News

BRNS SEC archive